The National Health Council (NHC) supports the nomination of Dr. Robert Califf as the next commissioner of the U.S. Food and Drug Administration (FDA).
The nomination awaits confirmation by the U.S. Senate. Califf was chosen for the office by member of the NHC.
“Dr. Califf has developed a proven track record of working with patients and other stakeholders to improve the lives of people with chronic diseases and disabilities,” NHC chief executive officer Marc Boutin said in a recent letter to the Senate.
While at Duke University, Califf was co-chair of the Clinical Trials Transformation Initiative (CTTI). He was also a principle investigator of PCORnet, the National Patient-Centered Clinical Research Network.
“FDA is committed to making patients a central focus of their work," Boutin said. "It is imperative that the next commissioner share these values and have a proven history of providing leadership in this area. The NHC can think of no better person who fits this bill than Rob Califf.”
NHC recommends Robert Califf as U.S. Food and Drug Administration commissioner